Croma-Pharma GmbH-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Croma-Pharma GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013122
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Croma-Pharma GmbH (Croma Pharma) is a pharmaceutical company which focuses on the development and commercialization of drugs in the field of aesthetic dermatology. It offers princess injectables, princess skincare, and princess lift products. The company’s princess skincare products comprise princess skincare serums and princess skincare masks. Croma Pharma offers princess lift products which include happy lift and PDO. It distributes its products in various countries through its own commercial sales organization and through strategic partnerships and distributors. The company operates through its subsidiaries in Belgium, Brazil, Canada, Germany, France, the Netherlands, Poland, Romania, Spain and the US. Croma Pharma is headquartered in Leobendorf, Austria.

Croma-Pharma GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Croma-Pharma GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Croma-Pharma GmbH, Medical Devices Deals, 2011 to YTD 2017 9
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Croma Pharma Enters Into Distribution Agreement With Hugel 11
Licensing Agreements 12
Croma-Pharma Enters into Licensing Agreement with Universkin 12
Asset Transactions 13
Valeant Pharma Acquires Medical Devices And Food Supplements Assets Of Croma-Pharma 13
Croma-Pharma GmbH – Key Competitors 14
Croma-Pharma GmbH – Key Employees 15
Croma-Pharma GmbH – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 18
Strategy And Business Planning 18
Feb 01, 2017: CROMA-PHARMA opens 12th subsidiary in Germany 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Croma-Pharma GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Croma-Pharma GmbH, Deals By Therapy Area, 2011 to YTD 2017 8
Croma-Pharma GmbH, Medical Devices Deals, 2011 to YTD 2017 9
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Croma Pharma Enters Into Distribution Agreement With Hugel 11
Croma-Pharma Enters into Licensing Agreement with Universkin 12
Valeant Pharma Acquires Medical Devices And Food Supplements Assets Of Croma-Pharma 13
Croma-Pharma GmbH, Key Competitors 14
Croma-Pharma GmbH, Key Employees 15
Croma-Pharma GmbH, Subsidiaries 16

★海外企業調査レポート[Croma-Pharma GmbH-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Resonance Health Ltd (RHT):医療機器:M&Aディール及び事業提携情報
    Summary Resonance Health Ltd (Resonance Health) is a healthcare solution provider that offers non-invasive medical imaging software and services. The company offers FerriScan analysis software for the measurement of liver iron concentration (LIC); FerriScan with Cardiac T2* dual analysis service to …
  • EXOR SpA:企業のM&A・事業提携・投資動向
    EXOR SpA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's EXOR SpA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Colgate-Palmolive (India) Ltd:企業の戦略・SWOT・財務情報
    Colgate-Palmolive (India) Ltd - Strategy, SWOT and Corporate Finance Report Summary Colgate-Palmolive (India) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Feintool International Holding AG (FTON):企業の財務・戦略的SWOT分析
    Feintool International Holding AG (FTON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Diamondback Energy Inc (FANG):企業の財務・戦略的SWOT分析
    Summary Diamondback Energy Inc (Diamondback Energy) operates as an oil and gas company that offers exploration and development programs. The company acquires, develops, explores and exploits unconventional, onshore oil and natural gas reserves in Permian Basin in West Texas. It develops the reserves …
  • General Electric Capital Corporation:戦略・SWOT・企業財務分析
    General Electric Capital Corporation - Strategy, SWOT and Corporate Finance Report Summary General Electric Capital Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Brown-Forman Corporation:企業の戦略・SWOT・財務分析
    Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report Summary Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Inovio Pharmaceuticals Inc (INO)-医療機器分野:企業M&A・提携分析
    Summary Inovio Pharmaceuticals Inc (Inovio) is a biotechnology company that focuses on developing a portfolio of DNA vaccines (immunotherapies) for the treatment and prevention of various cancers and infectious diseases. The company develops products based on its core SynCon DNA plasmid technology a …
  • Entek Energy Ltd (ETE):石油・ガス:M&Aディール及び事業提携情報
    Summary Entek Energy Limited (Entek Energy) is an upstream energy company that carries out the exploration, production and development of oil and gas reserves in addition to investment in the energy resources industry. It acquires oil and gas assets and explores conventional and unconventional sourc …
  • AVJennings Limited:企業の戦略・SWOT・財務情報
    AVJennings Limited - Strategy, SWOT and Corporate Finance Report Summary AVJennings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Grupa Azoty SA (ATT):企業の財務・戦略的SWOT分析
    Grupa Azoty SA (ATT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Catalyst Biosciences Inc (CBIO):企業の財務・戦略的SWOT分析
    Summary Catalyst Biosciences Inc (Catalyst Biosciences) is a clinical-stage biopharmaceutical company that develops protease-based advanced medicines to treat hematological indications. The company specializes in hemostasis, with focus on subcutaneous prophylaxis of hemophilia and surgery, and anti- …
  • Morgan Stanley Smith Barney LLC:企業の戦略的SWOT分析
    Morgan Stanley Smith Barney LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Kopin Corp (KOPN):企業の財務・戦略的SWOT分析
    Summary Kopin Corp (Kopin) is a technology company that offers wearable technologies and solutions. The company’s products comprise wearable headsets, transmissive liquid crystal displays, batteries, ASIC products, module products, whisper voice chip among others. Kopin technologies and solutions he …
  • Omega Pharma NV:製薬・医療:M&Aディール及び事業提携情報
    Summary Omega Pharma NV (Omega Pharma), a subsidiary of Perrigo Company plc, is a pharmaceutical company focusing on the development, manufacture and sale of prescription-free or Over the Counter (OTC) health and personal care products. The company's product portfolio includes cough and cold product …
  • COWI AS:企業の戦略的SWOT分析
    COWI AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Austevoll Seafood Asa:企業の戦略・SWOT・財務分析
    Austevoll Seafood Asa - Strategy, SWOT and Corporate Finance Report Summary Austevoll Seafood Asa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Canada Post Corporation:企業の戦略・SWOT・財務分析
    Canada Post Corporation - Strategy, SWOT and Corporate Finance Report Summary Canada Post Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Franklin Resources, Inc.:企業のM&A・事業提携・投資動向
    Franklin Resources, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Franklin Resources, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Aptose Biosciences Inc (APTO):企業の財務・戦略的SWOT分析
    Aptose Biosciences Inc (APTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆